although favourable clinical results have been obtained in patients with infections caused by mixed aerobic/anaerobic organisms ( such as peritonitis or soft tissue infections ) , the relatively low in vitro activity of cefotaxime against bacteroides fragilis may restrict its usage in situations where this organism is the suspected or proven pathogen .
C0149778
soft tissue infections
C0007554
cefotaxime